Introduction
The Immunization Agenda 2030 (IA2030) is an ambitious global immunisation strategy for the decade 2021–2030, designed to improve health security, universal health coverage (UHC), immunisation access and equity, and innovation, thereby saving an anticipated 50 million lives.1
The goal of reaching ‘zero-dose’ children—those who fail to receive basic vaccines—is a cornerstone of IA2030.1 Specifically, IA2030 aspires to achieve a 50% reduction in the number of zero-dose children (defined operationally as children who fail to receive the first dose of diphtheria, pertussis, tetanus (DTP)-containing vaccine) at country, regional and global levels, from an estimated 14 million in 2019 to 7 million in 2030.2
Designed to support the UN Sustainable Development Goals (SDGs) call to ‘leave no one behind’, the IA2030 zero-dose strategy diverges sharply from traditional vaccination initiatives. While vaccination strategies have usually been designed from a biomedical perspective to combat risks of death and disability due to specific infectious pathogens, delivery of the first dose of DTP vaccine does not in itself offer a meaningful health benefit. Rather, what motivates the new zero-dose focus is a commitment to equity informed by the social determinants of health. Worldwide, zero-dose children are believed to be among the poorest and most vulnerable.1 Reaching them is seen as a critical opportunity for ‘first contact’, which can be leveraged to deliver full vaccination and other services for zero-dose children, their families and communities, thereby strengthening primary healthcare and UHC.1 Via this approach, the zero-dose strategy aspires to contribute not only to child survival, but also to children’s ability to thrive and flourish,3 and to the SDG aim of transformative development.4 5
The child survival benefits of vaccination are well-established,6 and it is plausible that the IA2030 zero-dose strategy can help to reduce child mortality by delivering the benefits of full immunisation. Recent evidence from 90 low-income and middle-income countries demonstrates that almost 60% of children who receive the first dose of DTP vaccine go on to receive the full basic vaccination series.7 However, whether and how best the new zero-dose strategy can also contribute to transformative child development—children’s ability to survive, thrive and realise their full potential3—is less clear.
New empirical research suggests that zero-dose children are at high risk of mortality and failure to thrive. It underscores the intersecting forms of disadvantage and marginalisation faced by zero-dose children and their families, including barriers related to gender, poverty, education, and other socioeconomic and cultural factors, lower access to health services, and, in some contexts, higher prevalence of stunting and other forms of malnutrition.8–12 A focus on zero-dose children may thus be an appropriate policy entry point for a transformative strategy.
However, empirical evidence on medium-term and long-term developmental outcomes for zero-dose children is scant and the potential impacts of the zero-dose strategy on children’s ability to thrive therefore uncertain. We were unable to identify any empirical studies that trace longer-term outcomes for zero-dose children. We found only two studies documenting outcomes for the related theme of unvaccinated children, and these have important statistical and conceptual shortcomings. A 2012 observational study by Bloom and colleagues investigated the impact of early childhood immunisation on the height, weight and cognitive test scores of preadolescent children in the Philippines.13 Using propensity scores to compare fully vaccinated to unvaccinated children, the authors found that full immunisation had no effect on height or weight, but that it increased test scores, suggesting that vaccination may be a useful investment in human capital. This study used rigorous statistical methods but is limited by a small sample size of only 85 fully vaccinated children, and unobserved confounding.13 A 2022 observational study by Joe and Kumar Verma studied childhood vaccination and learning attainment in India, using two waves of the India Health and Development Survey (IHDS).14 The authors found that fully vaccinated children had better reading, writing and math performance than unvaccinated children, and argue that enhancing child vaccination coverage could improve educational outcomes.14 While based on a large, nationally representative sample, this study failed to consider the hierarchical structure of the data in the statistical analysis. It fitted a simple logistic regression without robust SEs which necessarily failed to account for data clustering. The SEs reported are likely to be too small, resulting in inflated type I errors that may lead to erroneous inference. Conceptually, both studies are limited by a focus on individual biomedical pathways (immunisation as a possible cause of poor learning attainment), rather than considering how complex forms of adversity (such as poverty, social exclusion, conflict and gender norms) interact to shape receipt of immunisation and learning outcomes in defined contexts. In the language of critical realist inquiry, these studies fail to investigate contexts, mechanisms and outcomes in configuration.15 Notwithstanding, as signalled in SDG 4.1, achievement of critical learning outcomes such as reading and mathematics can enable a transformative step-change in child development trajectories. The relationship between zero-dose vaccination status and learning attainment thus merits further investigation.
The strategy to reach zero-dose children and ‘missed’ communities (home to clusters of zero-dose and under-immunised children) is at the forefront of IA2030 and the 2021–2025 (‘5.0’) and 2023–2025 (‘5.1’) strategic plans for Gavi, the Vaccine Alliance. Gavi has made a direct investment of US$600 million to reach zero-dose children, and reoriented health system strengthening channels valued at US$1.2 billion towards these goals.16 These policies are motivated by a commitment to transformative change. Global stakeholders urgently require evidence to assess their potential impact and to strengthen intervention modalities.
India is a large and diverse country with the world’s second highest number of zero-dose children.17 In this study, we reanalysed data from the IHDS to examine the relationship between zero-dose vaccination status in early childhood and proficiency in reading, writing and numeracy at ages 8–11. Our analyses were informed by the nurturing care framework for human development, which links individual-level biological and social processes to wider contexts and policies.18 Commensurate with this framework, we hypothesised that vulnerability would be highest for zero-dose children living in contexts of grave deprivation. With a view to informing zero-dose policy, our objectives were to characterise the relationship between zero-dose vaccination status in early childhood and learning attainment in preadolescence, and to establish whether the level of community socioeconomic development moderates these relationships.